A comparative analysis of immunogenicity and safety of an enterovirus 71 vaccine between children aged 3-5 years and infants aged 6-35 months (English)
- New search for: Gu, Wei
- New search for: Zeng, Gang
- New search for: Hu, Yue-mei
- New search for: Hu, Yuan-Sheng
- New search for: Zhang, Ying
- New search for: Hu, Ya-ling
- New search for: Wang, Yang
- New search for: Li, Jing-Xin
- New search for: Zhu, Feng-Cai
- New search for: Gu, Wei
- New search for: Zeng, Gang
- New search for: Hu, Yue-mei
- New search for: Hu, Yuan-Sheng
- New search for: Zhang, Ying
- New search for: Hu, Ya-ling
- New search for: Wang, Yang
- New search for: Li, Jing-Xin
- New search for: Zhu, Feng-Cai
In:
Expert Review of Vaccines
;
17
, 3
;
257-262
;
2018
- Article (Journal) / Electronic Resource
-
Title:A comparative analysis of immunogenicity and safety of an enterovirus 71 vaccine between children aged 3-5 years and infants aged 6-35 months
-
Contributors:Gu, Wei ( author ) / Zeng, Gang ( author ) / Hu, Yue-mei ( author ) / Hu, Yuan-Sheng ( author ) / Zhang, Ying ( author ) / Hu, Ya-ling ( author ) / Wang, Yang ( author ) / Li, Jing-Xin ( author ) / Zhu, Feng-Cai ( author )
-
Published in:Expert Review of Vaccines ; 17, 3 ; 257-262
-
Publisher:
- New search for: Taylor & Francis
-
Publication date:2018-03-04
-
Size:6 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 17, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 189
-
Interpreting challenge data from early phase malaria blood stage vaccine trialsGood, Michael F. / Miller, Louis H. et al. | 2018
- 197
-
Extracellular vesicles from parasitic helminths and their potential utility as vaccinesMekonnen, Gebeyaw Getnet / Pearson, Mark / Loukas, Alex / Sotillo, Javier et al. | 2018
- 207
-
Current challenges for cancer vaccine adjuvant developmentBowen, William S. / Svrivastava, Abhishek K. / Batra, Lalit / Barsoumian, Hampartsoum / Shirwan, Haval et al. | 2018
- 217
-
Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehiclesSahu, Rajnish / Verma, Richa / Dixit, Saurabh / Igietseme, Joseph U. / Black, Carolyn M / Duncan, Skyla / Singh, Shree R / Dennis, Vida A et al. | 2018
- 229
-
Protecting UK adolescents and adults against meningococcal serogroup B diseaseVyse, Andrew / Ellsbury, Gillian / Madhava, Harish et al. | 2018
- 239
-
The potential of currently unavailable herpes virus vaccinesRajčáni, Július / Bánáti, Ferenc / Szenthe, Kálmán / Szathmary, Susan et al. | 2018
- 249
-
Exploratory study of the dispensing patterns of vaccines by a sample of community pharmacies in Southern AfricaTruter, Ilse et al. | 2018
- 257
-
A comparative analysis of immunogenicity and safety of an enterovirus 71 vaccine between children aged 3-5 years and infants aged 6-35 monthsGu, Wei / Zeng, Gang / Hu, Yue-mei / Hu, Yuan-Sheng / Zhang, Ying / Hu, Ya-ling / Wang, Yang / Li, Jing-Xin / Zhu, Feng-Cai et al. | 2018
- 263
-
A fuzzy MICMAC analysis for improving supply chain performance of basic vaccines in developing countriesChandra, Dheeraj / Kumar, Dinesh et al. | 2018